These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 18649055

  • 1. Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases.
    Oka H, Ikeda S, Koga S, Miyahara Y, Kohno S.
    Heart Vessels; 2008 Jul; 23(4):249-56. PubMed ID: 18649055
    [Abstract] [Full Text] [Related]

  • 2. Time-dependent effect of statins on platelet function in hypercholesterolaemia.
    Puccetti L, Pasqui AL, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, Angori P, Auteri A, Bruni F.
    Eur J Clin Invest; 2002 Dec; 32(12):901-8. PubMed ID: 12534449
    [Abstract] [Full Text] [Related]

  • 3. Effects of short-term atorvastatin treatment on global fibrinolytic capacity, and sL-selectin and sFas levels in hyperlipidemic patients with coronary artery disease.
    Atalar E, Ozmen F, Haznedaroglu I, Açil T, Ozer N, Ovünç K, Aksöyek S, Kes S.
    Int J Cardiol; 2002 Aug; 84(2-3):227-31. PubMed ID: 12127376
    [Abstract] [Full Text] [Related]

  • 4. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1035-42. PubMed ID: 17349882
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.
    Puccetti L, Sawamura T, Pasqui AL, Pastorelli M, Auteri A, Bruni F.
    Eur J Clin Invest; 2005 Jan 13; 35(1):47-51. PubMed ID: 15638819
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 8. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 10; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 9. Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.
    Pontrelli L, Parris W, Adeli K, Cheung RC.
    Metabolism; 2002 Mar 10; 51(3):334-42. PubMed ID: 11887170
    [Abstract] [Full Text] [Related]

  • 10. Effect of atorvastatin on low-density lipoprotein subpopulations and comparison between indicators of plasma atherogenicity: a pilot study.
    Kucera M, Oravec S, Hirnerova E, Huckova N, Celecova Z, Gaspar L, Banach M.
    Angiology; 2014 Oct 10; 65(9):794-9. PubMed ID: 24163116
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J, CAP Investigators.
    Clin Ther; 2008 Dec 10; 30(12):2298-313. PubMed ID: 19167589
    [Abstract] [Full Text] [Related]

  • 15. The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia.
    Kural BV, Orem C, Uydu HA, Alver A, Orem A.
    Coron Artery Dis; 2004 Aug 10; 15(5):277-83. PubMed ID: 15238825
    [Abstract] [Full Text] [Related]

  • 16. The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients.
    Thallinger C, Urbauer E, Lackner E, Graselli U, Kostner K, Wolzt M, Joukhadar C.
    Int J Clin Pharmacol Ther; 2005 Dec 10; 43(12):551-7. PubMed ID: 16372516
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
    Schwartz GG, Bolognese MA, Tremblay BP, Caplan R, Hutchinson H, Raza A, Cressman M.
    Am Heart J; 2004 Jul 10; 148(1):e4. PubMed ID: 15215813
    [Abstract] [Full Text] [Related]

  • 18. 3'UTR/T polymorphism of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is associated with modified anti-platelet activity of atorvastatin in hypercholesterolemic subjects.
    Puccetti L, Pasqui AL, Pastorelli M, Ciani F, Palazzuoli A, Gioffrè W, Auteri A, Bruni F.
    Atherosclerosis; 2005 Dec 10; 183(2):322-8. PubMed ID: 16285995
    [Abstract] [Full Text] [Related]

  • 19. Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin.
    Pignatelli P, Sanguigni V, Lenti L, Loffredo L, Carnevale R, Sorge R, Violi F.
    J Thromb Haemost; 2007 Jun 10; 5(6):1170-8. PubMed ID: 17388962
    [Abstract] [Full Text] [Related]

  • 20. Effects of atorvastatin on coagulation parameters and homocysteine in patients with primary hypercholesterolemia.
    Bolaman Z, Kadikoylu G, Ozgel N, Yenisey C.
    J Natl Med Assoc; 2006 Aug 10; 98(8):1273-7. PubMed ID: 16916124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.